Patents by Inventor Gary Jay Dozeman

Gary Jay Dozeman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
    Patent number: 7141608
    Abstract: Alcohol and water solvates of 6-(5-carboxy-5-methyl-hexyloxy)-2,2-dimethylhexanoic acid monocalcium salt are crystalline and have the formula wherein R1 is H or lower alkyl, and x is a number from 0 to 10, and are useful for treating dyslipidemia.
    Type: Grant
    Filed: September 10, 2004
    Date of Patent: November 28, 2006
    Assignee: Warmer-Lambert Company LLC
    Inventors: Howard Yoshihisa Ando, Donald Eugene Butler, Gary Jay Dozeman
  • Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
    Patent number: 6861555
    Abstract: Alcohol and water solvates of 6-(5-carboxy-5-methyl-hexyloxy)-2,2-dimethylhexanoic acid monocalcium salt are crystalline and have the formula (I), wherein R1 is H or lower alkyl, and x is a number from 0 to 10, and are useful for treating dyslipidemia.
    Type: Grant
    Filed: January 11, 2001
    Date of Patent: March 1, 2005
    Assignee: Warner-Lambert Company
    Inventors: Howard Yoshihisa Ando, Donald Eugene Butler, Gary Jay Dozeman
  • Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
    Publication number: 20030119912
    Abstract: Alcohol and water solvates of 6-(5-carboxy-5-methyl-hexyloxy)-2,2-dimethylhexonoic acid monocalcium salt are crystalline and have the formula (I), wherein R1 is H or lower alkyl, and x is a number from 0 to 10, and are useful for treating dyslipidemia.
    Type: Application
    Filed: December 17, 2001
    Publication date: June 26, 2003
    Inventors: Howard Yoshihisa Ando, Donald Eugene Butler, Gary Jay Dozeman
  • Solid bulk compositions containing quinolone carboxylic acids or naphthyridine carboxylic acids in free base form
    Patent number: 5783585
    Abstract: The present invention provides a method of making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form, the method comprising dissolving a quinolone carboxylic acid salt or naphthyridine carboxylic acid salt in a solvent system to form a solution; combining the solution containing the quinolone carboxylic acid salt or naphthyridine carboxylic acid salt with a calcium salt in an amount in the range of about 0.01% to about 5.0% by weight of the quinolone carboxylic acid salt or naphthyridine carboxylic acid salt and a base, the combination resulting in the formation of a precipitate; and collecting the precipitate. Also provided is a solid bulk pharmaceutical chemical composition comprising 7-(3-amino-1-pyrrolidinyl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-o xoquinoline-3-carboxylic acid or 7-?3-S-(2-S-aminopropionylamino)pyrrolidin-1-yl!-1-cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid; and calcium in an amount in the range of 0.001% to about 1.
    Type: Grant
    Filed: September 30, 1996
    Date of Patent: July 21, 1998
    Assignee: Warner-Lambert Company
    Inventors: Gary Jay Dozeman, Kenneth Thomas Porter, James Norton Wemple